Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lexaria Bioscience Corp. Director's Dealing 2015

Nov 17, 2015

34983_dirs_2015-11-17_8ab640e9-eb9d-40c2-a677-8892747509ab.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2015-09-16

Reporting Person: McKechnie William Edward (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-09-16 Stock Options $0.19 P 100000 Acquired 2020-09-16 Common Shares (100000) Direct